nodes	percent_of_prediction	percent_of_DWPC	metapath
Topiramate—CYP3A4—Fingolimod—multiple sclerosis	0.0197	0.186	CbGbCtD
Topiramate—GRIK1—peripheral nervous system—multiple sclerosis	0.0169	0.0509	CbGeAlD
Topiramate—CYP2C19—Prednisone—multiple sclerosis	0.0159	0.15	CbGbCtD
Topiramate—GRIA4—nerve—multiple sclerosis	0.015	0.0453	CbGeAlD
Topiramate—GRIK1—nerve—multiple sclerosis	0.0131	0.0397	CbGeAlD
Topiramate—CYP3A4—Methylprednisolone—multiple sclerosis	0.0127	0.12	CbGbCtD
Topiramate—GRIA3—nerve—multiple sclerosis	0.0122	0.0369	CbGeAlD
Topiramate—CYP2C19—Dexamethasone—multiple sclerosis	0.00992	0.0937	CbGbCtD
Topiramate—CYP3A4—Triamcinolone—multiple sclerosis	0.00961	0.0908	CbGbCtD
Topiramate—CYP3A4—Mitoxantrone—multiple sclerosis	0.00925	0.0874	CbGbCtD
Topiramate—CYP3A4—Betamethasone—multiple sclerosis	0.00824	0.0779	CbGbCtD
Topiramate—CYP3A4—Prednisolone—multiple sclerosis	0.00813	0.0768	CbGbCtD
Topiramate—CYP3A4—Prednisone—multiple sclerosis	0.00768	0.0726	CbGbCtD
Topiramate—GRIA1—nerve—multiple sclerosis	0.00653	0.0197	CbGeAlD
Topiramate—GRIA4—brainstem—multiple sclerosis	0.00644	0.0194	CbGeAlD
Topiramate—GRIA4—retina—multiple sclerosis	0.00621	0.0188	CbGeAlD
Topiramate—GRIK5—brainstem—multiple sclerosis	0.00594	0.0179	CbGeAlD
Topiramate—GRIK3—retina—multiple sclerosis	0.00573	0.0173	CbGeAlD
Topiramate—GRIK1—brainstem—multiple sclerosis	0.00564	0.017	CbGeAlD
Topiramate—GRIK1—retina—multiple sclerosis	0.00545	0.0164	CbGeAlD
Topiramate—CYP3A4—Dexamethasone—multiple sclerosis	0.0048	0.0453	CbGbCtD
Topiramate—GRIK2—nerve—multiple sclerosis	0.00468	0.0141	CbGeAlD
Topiramate—GRIA4—medulla oblongata—multiple sclerosis	0.00449	0.0136	CbGeAlD
Topiramate—GRIK4—nervous system—multiple sclerosis	0.00427	0.0129	CbGeAlD
Topiramate—GRIK5—medulla oblongata—multiple sclerosis	0.00414	0.0125	CbGeAlD
Topiramate—GRIK3—medulla oblongata—multiple sclerosis	0.00414	0.0125	CbGeAlD
Topiramate—GRIK4—central nervous system—multiple sclerosis	0.00411	0.0124	CbGeAlD
Topiramate—GRIK4—cerebellum—multiple sclerosis	0.00401	0.0121	CbGeAlD
Topiramate—GRIA4—spinal cord—multiple sclerosis	0.004	0.0121	CbGeAlD
Topiramate—GRIK1—medulla oblongata—multiple sclerosis	0.00394	0.0119	CbGeAlD
Topiramate—GRIK5—midbrain—multiple sclerosis	0.00379	0.0114	CbGeAlD
Topiramate—GRIK3—midbrain—multiple sclerosis	0.00379	0.0114	CbGeAlD
Topiramate—GRIK5—spinal cord—multiple sclerosis	0.00369	0.0112	CbGeAlD
Topiramate—GRIK3—spinal cord—multiple sclerosis	0.00369	0.0112	CbGeAlD
Topiramate—GRIA3—medulla oblongata—multiple sclerosis	0.00366	0.0111	CbGeAlD
Topiramate—GRIK1—midbrain—multiple sclerosis	0.0036	0.0109	CbGeAlD
Topiramate—GRIK1—spinal cord—multiple sclerosis	0.00351	0.0106	CbGeAlD
Topiramate—CA1—nerve—multiple sclerosis	0.00347	0.0105	CbGeAlD
Topiramate—GRIA4—nervous system—multiple sclerosis	0.00337	0.0102	CbGeAlD
Topiramate—GRIA3—midbrain—multiple sclerosis	0.00334	0.0101	CbGeAlD
Topiramate—GRIA3—spinal cord—multiple sclerosis	0.00326	0.00986	CbGeAlD
Topiramate—GRIK4—brain—multiple sclerosis	0.00326	0.00985	CbGeAlD
Topiramate—GRIA4—central nervous system—multiple sclerosis	0.00325	0.00981	CbGeAlD
Topiramate—GRIA4—cerebellum—multiple sclerosis	0.00317	0.00959	CbGeAlD
Topiramate—GRIK5—nervous system—multiple sclerosis	0.00311	0.0094	CbGeAlD
Topiramate—GRIK3—nervous system—multiple sclerosis	0.00311	0.0094	CbGeAlD
Topiramate—GRIK5—central nervous system—multiple sclerosis	0.003	0.00905	CbGeAlD
Topiramate—GRIK3—central nervous system—multiple sclerosis	0.003	0.00905	CbGeAlD
Topiramate—GRIK1—nervous system—multiple sclerosis	0.00296	0.00893	CbGeAlD
Topiramate—GRIK5—cerebellum—multiple sclerosis	0.00293	0.00885	CbGeAlD
Topiramate—GRIK3—cerebellum—multiple sclerosis	0.00293	0.00885	CbGeAlD
Topiramate—GRIK1—central nervous system—multiple sclerosis	0.00285	0.0086	CbGeAlD
Topiramate—GRIA1—brainstem—multiple sclerosis	0.0028	0.00846	CbGeAlD
Topiramate—GRIK1—cerebellum—multiple sclerosis	0.00278	0.00841	CbGeAlD
Topiramate—GRIA3—nervous system—multiple sclerosis	0.00275	0.0083	CbGeAlD
Topiramate—CA4—nerve—multiple sclerosis	0.00271	0.00819	CbGeAlD
Topiramate—GRIA1—retina—multiple sclerosis	0.0027	0.00817	CbGeAlD
Topiramate—GRIA3—central nervous system—multiple sclerosis	0.00265	0.008	CbGeAlD
Topiramate—GRIA3—cerebellum—multiple sclerosis	0.00259	0.00781	CbGeAlD
Topiramate—GRIA4—brain—multiple sclerosis	0.00258	0.00779	CbGeAlD
Topiramate—GRIK5—brain—multiple sclerosis	0.00238	0.00719	CbGeAlD
Topiramate—GRIK3—brain—multiple sclerosis	0.00238	0.00719	CbGeAlD
Topiramate—GRIK1—brain—multiple sclerosis	0.00226	0.00683	CbGeAlD
Topiramate—GRIA2—brainstem—multiple sclerosis	0.00223	0.00672	CbGeAlD
Topiramate—GRIA3—brain—multiple sclerosis	0.0021	0.00635	CbGeAlD
Topiramate—SCN1A—brainstem—multiple sclerosis	0.00203	0.00613	CbGeAlD
Topiramate—GRIK2—brainstem—multiple sclerosis	0.00201	0.00607	CbGeAlD
Topiramate—GRIA1—medulla oblongata—multiple sclerosis	0.00195	0.0059	CbGeAlD
Topiramate—GRIK2—retina—multiple sclerosis	0.00194	0.00586	CbGeAlD
Topiramate—CA7—midbrain—multiple sclerosis	0.00184	0.00557	CbGeAlD
Topiramate—GRIA1—midbrain—multiple sclerosis	0.00179	0.00539	CbGeAlD
Topiramate—GRIA1—spinal cord—multiple sclerosis	0.00174	0.00526	CbGeAlD
Topiramate—GABRB2—brainstem—multiple sclerosis	0.00158	0.00478	CbGeAlD
Topiramate—GRIA1—nervous system—multiple sclerosis	0.00147	0.00443	CbGeAlD
Topiramate—CA7—cerebellum—multiple sclerosis	0.00143	0.00431	CbGeAlD
Topiramate—GRIA2—midbrain—multiple sclerosis	0.00142	0.00428	CbGeAlD
Topiramate—SCN1A—medulla oblongata—multiple sclerosis	0.00142	0.00428	CbGeAlD
Topiramate—GRIA1—central nervous system—multiple sclerosis	0.00141	0.00427	CbGeAlD
Topiramate—GRIK2—medulla oblongata—multiple sclerosis	0.0014	0.00424	CbGeAlD
Topiramate—GABRA1—brainstem—multiple sclerosis	0.0014	0.00422	CbGeAlD
Topiramate—GRIA2—spinal cord—multiple sclerosis	0.00138	0.00418	CbGeAlD
Topiramate—GRIA1—cerebellum—multiple sclerosis	0.00138	0.00417	CbGeAlD
Topiramate—SCN1A—midbrain—multiple sclerosis	0.00129	0.00391	CbGeAlD
Topiramate—GRIK2—midbrain—multiple sclerosis	0.00128	0.00387	CbGeAlD
Topiramate—SCN1A—spinal cord—multiple sclerosis	0.00126	0.00381	CbGeAlD
Topiramate—CA9—cerebellum—multiple sclerosis	0.00125	0.00378	CbGeAlD
Topiramate—GRIK2—spinal cord—multiple sclerosis	0.00125	0.00378	CbGeAlD
Topiramate—GRIA2—nervous system—multiple sclerosis	0.00117	0.00352	CbGeAlD
Topiramate—CA4—brainstem—multiple sclerosis	0.00116	0.00351	CbGeAlD
Topiramate—CA7—brain—multiple sclerosis	0.00116	0.0035	CbGeAlD
Topiramate—GRIA2—central nervous system—multiple sclerosis	0.00112	0.00339	CbGeAlD
Topiramate—GRIA1—brain—multiple sclerosis	0.00112	0.00339	CbGeAlD
Topiramate—GABRB2—medulla oblongata—multiple sclerosis	0.0011	0.00333	CbGeAlD
Topiramate—GABRG2—medulla oblongata—multiple sclerosis	0.0011	0.00333	CbGeAlD
Topiramate—GRIA2—cerebellum—multiple sclerosis	0.0011	0.00331	CbGeAlD
Topiramate—SCN1A—nervous system—multiple sclerosis	0.00106	0.00321	CbGeAlD
Topiramate—GRIK2—nervous system—multiple sclerosis	0.00105	0.00318	CbGeAlD
Topiramate—SCN1A—central nervous system—multiple sclerosis	0.00102	0.00309	CbGeAlD
Topiramate—GRIK2—central nervous system—multiple sclerosis	0.00101	0.00306	CbGeAlD
Topiramate—GABRB2—midbrain—multiple sclerosis	0.00101	0.00305	CbGeAlD
Topiramate—GABRG2—midbrain—multiple sclerosis	0.00101	0.00305	CbGeAlD
Topiramate—SCN1A—cerebellum—multiple sclerosis	0.001	0.00302	CbGeAlD
Topiramate—GRIK2—cerebellum—multiple sclerosis	0.000991	0.00299	CbGeAlD
Topiramate—CA12—nervous system—multiple sclerosis	0.000984	0.00297	CbGeAlD
Topiramate—GABRB2—spinal cord—multiple sclerosis	0.000984	0.00297	CbGeAlD
Topiramate—GABRG2—spinal cord—multiple sclerosis	0.000984	0.00297	CbGeAlD
Topiramate—GABRA1—medulla oblongata—multiple sclerosis	0.000975	0.00294	CbGeAlD
Topiramate—CA2—brainstem—multiple sclerosis	0.000965	0.00291	CbGeAlD
Topiramate—CA12—central nervous system—multiple sclerosis	0.000948	0.00286	CbGeAlD
Topiramate—CA2—retina—multiple sclerosis	0.000931	0.00281	CbGeAlD
Topiramate—CA1—spinal cord—multiple sclerosis	0.000926	0.0028	CbGeAlD
Topiramate—GRIA2—brain—multiple sclerosis	0.000891	0.00269	CbGeAlD
Topiramate—GABRA1—midbrain—multiple sclerosis	0.000891	0.00269	CbGeAlD
Topiramate—CA5B—nervous system—multiple sclerosis	0.000883	0.00267	CbGeAlD
Topiramate—GABRA1—spinal cord—multiple sclerosis	0.000869	0.00263	CbGeAlD
Topiramate—SCN5A—nervous system—multiple sclerosis	0.000856	0.00258	CbGeAlD
Topiramate—CA5B—central nervous system—multiple sclerosis	0.00085	0.00257	CbGeAlD
Topiramate—GABRB2—nervous system—multiple sclerosis	0.000829	0.00251	CbGeAlD
Topiramate—GABRG2—nervous system—multiple sclerosis	0.000829	0.00251	CbGeAlD
Topiramate—SCN5A—central nervous system—multiple sclerosis	0.000824	0.00249	CbGeAlD
Topiramate—SCN1A—brain—multiple sclerosis	0.000813	0.00246	CbGeAlD
Topiramate—CA4—medulla oblongata—multiple sclerosis	0.000811	0.00245	CbGeAlD
Topiramate—GRIK2—brain—multiple sclerosis	0.000805	0.00243	CbGeAlD
Topiramate—GABRB2—central nervous system—multiple sclerosis	0.000799	0.00241	CbGeAlD
Topiramate—GABRG2—central nervous system—multiple sclerosis	0.000799	0.00241	CbGeAlD
Topiramate—GABRB2—cerebellum—multiple sclerosis	0.000781	0.00236	CbGeAlD
Topiramate—GABRG2—cerebellum—multiple sclerosis	0.000781	0.00236	CbGeAlD
Topiramate—CA1—nervous system—multiple sclerosis	0.00078	0.00236	CbGeAlD
Topiramate—CA12—brain—multiple sclerosis	0.000752	0.00227	CbGeAlD
Topiramate—CA1—central nervous system—multiple sclerosis	0.000751	0.00227	CbGeAlD
Topiramate—CA4—midbrain—multiple sclerosis	0.000741	0.00224	CbGeAlD
Topiramate—GABRA1—nervous system—multiple sclerosis	0.000732	0.00221	CbGeAlD
Topiramate—CA4—spinal cord—multiple sclerosis	0.000723	0.00219	CbGeAlD
Topiramate—GABRA1—central nervous system—multiple sclerosis	0.000705	0.00213	CbGeAlD
Topiramate—GABRA1—cerebellum—multiple sclerosis	0.000689	0.00208	CbGeAlD
Topiramate—CA5B—brain—multiple sclerosis	0.000675	0.00204	CbGeAlD
Topiramate—CA2—medulla oblongata—multiple sclerosis	0.000673	0.00203	CbGeAlD
Topiramate—SCN5A—brain—multiple sclerosis	0.000654	0.00198	CbGeAlD
Topiramate—GABRB2—brain—multiple sclerosis	0.000634	0.00192	CbGeAlD
Topiramate—GABRG2—brain—multiple sclerosis	0.000634	0.00192	CbGeAlD
Topiramate—CA2—midbrain—multiple sclerosis	0.000615	0.00186	CbGeAlD
Topiramate—CA4—nervous system—multiple sclerosis	0.00061	0.00184	CbGeAlD
Topiramate—CA2—spinal cord—multiple sclerosis	0.0006	0.00181	CbGeAlD
Topiramate—CA1—brain—multiple sclerosis	0.000596	0.0018	CbGeAlD
Topiramate—CA4—central nervous system—multiple sclerosis	0.000587	0.00177	CbGeAlD
Topiramate—CA4—cerebellum—multiple sclerosis	0.000574	0.00173	CbGeAlD
Topiramate—GABRA1—brain—multiple sclerosis	0.00056	0.00169	CbGeAlD
Topiramate—CA2—nervous system—multiple sclerosis	0.000505	0.00153	CbGeAlD
Topiramate—CA2—central nervous system—multiple sclerosis	0.000487	0.00147	CbGeAlD
Topiramate—CA2—cerebellum—multiple sclerosis	0.000476	0.00144	CbGeAlD
Topiramate—CA4—brain—multiple sclerosis	0.000466	0.00141	CbGeAlD
Topiramate—CA2—brain—multiple sclerosis	0.000386	0.00117	CbGeAlD
Topiramate—GRIA1—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000344	0.00367	CbGpPWpGaD
Topiramate—GRIA1—BDNF signaling pathway—BDNF—multiple sclerosis	0.000343	0.00366	CbGpPWpGaD
Topiramate—CYP3A4—nervous system—multiple sclerosis	0.000326	0.000985	CbGeAlD
Topiramate—GRIK2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000314	0.00336	CbGpPWpGaD
Topiramate—CYP3A4—central nervous system—multiple sclerosis	0.000314	0.000948	CbGeAlD
Topiramate—GRIA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	0.000307	0.00328	CbGpPWpGaD
Topiramate—GRIA2—Hypothetical Network for Drug Addiction—MAPK1—multiple sclerosis	0.000304	0.00325	CbGpPWpGaD
Topiramate—GRIA1—BDNF signaling pathway—SPP1—multiple sclerosis	0.000304	0.00325	CbGpPWpGaD
Topiramate—CA5A—Metabolism—SRM—multiple sclerosis	0.000299	0.0032	CbGpPWpGaD
Topiramate—CA6—Metabolism—SRM—multiple sclerosis	0.000299	0.0032	CbGpPWpGaD
Topiramate—GRIA2—BDNF signaling pathway—CNR1—multiple sclerosis	0.000296	0.00316	CbGpPWpGaD
Topiramate—GRIK5—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.000292	0.00312	CbGpPWpGaD
Topiramate—GRIK4—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.000292	0.00312	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—PRNP—multiple sclerosis	0.00028	0.00299	CbGpPWpGaD
Topiramate—CA5B—Metabolism—SRM—multiple sclerosis	0.000279	0.00298	CbGpPWpGaD
Topiramate—CA7—Metabolism—SRM—multiple sclerosis	0.000279	0.00298	CbGpPWpGaD
Topiramate—GRIK1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.000272	0.0029	CbGpPWpGaD
Topiramate—GRIK3—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.000272	0.0029	CbGpPWpGaD
Topiramate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000269	0.00287	CbGpPWpGaD
Topiramate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000269	0.00287	CbGpPWpGaD
Topiramate—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000265	0.00283	CbGpPWpGaD
Topiramate—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000265	0.00283	CbGpPWpGaD
Topiramate—GRIA1—Neuronal System—BCHE—multiple sclerosis	0.000263	0.00281	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	0.000261	0.00279	CbGpPWpGaD
Topiramate—CA12—Metabolism—SRM—multiple sclerosis	0.000259	0.00277	CbGpPWpGaD
Topiramate—CA1—C-MYB transcription factor network—CD4—multiple sclerosis	0.000251	0.00268	CbGpPWpGaD
Topiramate—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—MAPK1—multiple sclerosis	0.00025	0.00267	CbGpPWpGaD
Topiramate—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000241	0.00258	CbGpPWpGaD
Topiramate—GRIK2—Neuronal System—BCHE—multiple sclerosis	0.000241	0.00257	CbGpPWpGaD
Topiramate—GRIA2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.00024	0.00257	CbGpPWpGaD
Topiramate—GRIA3—BDNF signaling pathway—STAT3—multiple sclerosis	0.00024	0.00256	CbGpPWpGaD
Topiramate—GRIA2—BDNF signaling pathway—BDNF—multiple sclerosis	0.00024	0.00256	CbGpPWpGaD
Topiramate—GRIA4—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.000231	0.00247	CbGpPWpGaD
Topiramate—GRIK5—Neuronal System—MAPK1—multiple sclerosis	0.000224	0.00239	CbGpPWpGaD
Topiramate—GRIK4—Neuronal System—MAPK1—multiple sclerosis	0.000224	0.00239	CbGpPWpGaD
Topiramate—GRIA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	0.000223	0.00238	CbGpPWpGaD
Topiramate—GRIA3—BDNF signaling pathway—MAPK1—multiple sclerosis	0.000218	0.00233	CbGpPWpGaD
Topiramate—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000218	0.00233	CbGpPWpGaD
Topiramate—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000218	0.00233	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—PTPRC—multiple sclerosis	0.000217	0.00232	CbGpPWpGaD
Topiramate—GRIA2—BDNF signaling pathway—SPP1—multiple sclerosis	0.000213	0.00227	CbGpPWpGaD
Topiramate—CA5A—Metabolism—CYP27B1—multiple sclerosis	0.000211	0.00225	CbGpPWpGaD
Topiramate—CA6—Metabolism—CYP27B1—multiple sclerosis	0.000211	0.00225	CbGpPWpGaD
Topiramate—CA6—Metabolism—CYP24A1—multiple sclerosis	0.000211	0.00225	CbGpPWpGaD
Topiramate—CA5A—Metabolism—CYP24A1—multiple sclerosis	0.000211	0.00225	CbGpPWpGaD
Topiramate—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000209	0.00224	CbGpPWpGaD
Topiramate—GRIK1—Neuronal System—MAPK1—multiple sclerosis	0.000208	0.00222	CbGpPWpGaD
Topiramate—GRIK3—Neuronal System—MAPK1—multiple sclerosis	0.000208	0.00222	CbGpPWpGaD
Topiramate—CA4—Metabolism—SRM—multiple sclerosis	0.000206	0.00221	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.000205	0.00219	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—IFNB1—multiple sclerosis	0.000201	0.00215	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—PRNP—multiple sclerosis	0.0002	0.00213	CbGpPWpGaD
Topiramate—CA2—Metabolism—SRM—multiple sclerosis	0.000198	0.00211	CbGpPWpGaD
Topiramate—CA7—Metabolism—CYP27B1—multiple sclerosis	0.000197	0.0021	CbGpPWpGaD
Topiramate—CA5B—Metabolism—CYP24A1—multiple sclerosis	0.000197	0.0021	CbGpPWpGaD
Topiramate—CA7—Metabolism—CYP24A1—multiple sclerosis	0.000197	0.0021	CbGpPWpGaD
Topiramate—CA5B—Metabolism—CYP27B1—multiple sclerosis	0.000197	0.0021	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—PRNP—multiple sclerosis	0.000197	0.0021	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.000195	0.00209	CbGpPWpGaD
Topiramate—CA5A—Metabolism—GPC5—multiple sclerosis	0.000193	0.00206	CbGpPWpGaD
Topiramate—CA6—Metabolism—GPC5—multiple sclerosis	0.000193	0.00206	CbGpPWpGaD
Topiramate—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	0.000192	0.00206	CbGpPWpGaD
Topiramate—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	0.000192	0.00206	CbGpPWpGaD
Topiramate—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.00019	0.00203	CbGpPWpGaD
Topiramate—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.00019	0.00203	CbGpPWpGaD
Topiramate—CA1—Metabolism—SRM—multiple sclerosis	0.00019	0.00203	CbGpPWpGaD
Topiramate—SCN5A—Cardiac Progenitor Differentiation—TGFB1—multiple sclerosis	0.000189	0.00202	CbGpPWpGaD
Topiramate—Paraesthesia—Prednisolone—multiple sclerosis	0.000186	0.000397	CcSEcCtD
Topiramate—Tachycardia—Triamcinolone—multiple sclerosis	0.000186	0.000397	CcSEcCtD
Topiramate—Mental disorder—Prednisone—multiple sclerosis	0.000186	0.000396	CcSEcCtD
Topiramate—Nausea—Azathioprine—multiple sclerosis	0.000186	0.000396	CcSEcCtD
Topiramate—Tachycardia—Methylprednisolone—multiple sclerosis	0.000186	0.000396	CcSEcCtD
Topiramate—Skin disorder—Methylprednisolone—multiple sclerosis	0.000185	0.000394	CcSEcCtD
Topiramate—Erythema—Prednisone—multiple sclerosis	0.000185	0.000393	CcSEcCtD
Topiramate—Malnutrition—Prednisone—multiple sclerosis	0.000185	0.000393	CcSEcCtD
Topiramate—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000184	0.000393	CcSEcCtD
Topiramate—Agranulocytosis—Methotrexate—multiple sclerosis	0.000184	0.000393	CcSEcCtD
Topiramate—GRIA2—Neuronal System—BCHE—multiple sclerosis	0.000184	0.00197	CbGpPWpGaD
Topiramate—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000184	0.000392	CcSEcCtD
Topiramate—GABRB2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000184	0.00196	CbGpPWpGaD
Topiramate—Convulsion—Dexamethasone—multiple sclerosis	0.000184	0.000391	CcSEcCtD
Topiramate—Convulsion—Betamethasone—multiple sclerosis	0.000184	0.000391	CcSEcCtD
Topiramate—Hypertension—Dexamethasone—multiple sclerosis	0.000183	0.00039	CcSEcCtD
Topiramate—Hypertension—Betamethasone—multiple sclerosis	0.000183	0.00039	CcSEcCtD
Topiramate—CA12—Metabolism—CYP24A1—multiple sclerosis	0.000182	0.00195	CbGpPWpGaD
Topiramate—CA12—Metabolism—CYP27B1—multiple sclerosis	0.000182	0.00195	CbGpPWpGaD
Topiramate—Asthenia—Mitoxantrone—multiple sclerosis	0.000181	0.000386	CcSEcCtD
Topiramate—GABRB2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000181	0.00193	CbGpPWpGaD
Topiramate—Myalgia—Betamethasone—multiple sclerosis	0.000181	0.000385	CcSEcCtD
Topiramate—Myalgia—Dexamethasone—multiple sclerosis	0.000181	0.000385	CcSEcCtD
Topiramate—CA1—C-MYB transcription factor network—MYC—multiple sclerosis	0.00018	0.00193	CbGpPWpGaD
Topiramate—CA5B—Metabolism—GPC5—multiple sclerosis	0.00018	0.00192	CbGpPWpGaD
Topiramate—CA7—Metabolism—GPC5—multiple sclerosis	0.00018	0.00192	CbGpPWpGaD
Topiramate—Anxiety—Dexamethasone—multiple sclerosis	0.00018	0.000383	CcSEcCtD
Topiramate—Anxiety—Betamethasone—multiple sclerosis	0.00018	0.000383	CcSEcCtD
Topiramate—Discomfort—Dexamethasone—multiple sclerosis	0.000178	0.00038	CcSEcCtD
Topiramate—Discomfort—Betamethasone—multiple sclerosis	0.000178	0.00038	CcSEcCtD
Topiramate—Haemoglobin—Methotrexate—multiple sclerosis	0.000178	0.00038	CcSEcCtD
Topiramate—Hypotension—Methylprednisolone—multiple sclerosis	0.000178	0.000379	CcSEcCtD
Topiramate—Pain—Prednisolone—multiple sclerosis	0.000177	0.000378	CcSEcCtD
Topiramate—Haemorrhage—Methotrexate—multiple sclerosis	0.000177	0.000378	CcSEcCtD
Topiramate—Hepatitis—Methotrexate—multiple sclerosis	0.000177	0.000378	CcSEcCtD
Topiramate—GRIA4—Neuronal System—MAPK1—multiple sclerosis	0.000177	0.00189	CbGpPWpGaD
Topiramate—Pharyngitis—Methotrexate—multiple sclerosis	0.000176	0.000375	CcSEcCtD
Topiramate—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000175	0.000373	CcSEcCtD
Topiramate—Vision blurred—Prednisone—multiple sclerosis	0.000174	0.000371	CcSEcCtD
Topiramate—Urethral disorder—Methotrexate—multiple sclerosis	0.000174	0.00037	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000174	0.00037	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000173	0.000369	CcSEcCtD
Topiramate—Oedema—Betamethasone—multiple sclerosis	0.000173	0.000369	CcSEcCtD
Topiramate—Oedema—Dexamethasone—multiple sclerosis	0.000173	0.000369	CcSEcCtD
Topiramate—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000173	0.000369	CcSEcCtD
Topiramate—Insomnia—Triamcinolone—multiple sclerosis	0.000173	0.000368	CcSEcCtD
Topiramate—Insomnia—Methylprednisolone—multiple sclerosis	0.000172	0.000367	CcSEcCtD
Topiramate—Infection—Betamethasone—multiple sclerosis	0.000172	0.000366	CcSEcCtD
Topiramate—Infection—Dexamethasone—multiple sclerosis	0.000172	0.000366	CcSEcCtD
Topiramate—Ill-defined disorder—Prednisone—multiple sclerosis	0.000171	0.000365	CcSEcCtD
Topiramate—Paraesthesia—Triamcinolone—multiple sclerosis	0.000171	0.000365	CcSEcCtD
Topiramate—Feeling abnormal—Prednisolone—multiple sclerosis	0.000171	0.000364	CcSEcCtD
Topiramate—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000171	0.000364	CcSEcCtD
Topiramate—Visual impairment—Methotrexate—multiple sclerosis	0.000171	0.000364	CcSEcCtD
Topiramate—Anaemia—Prednisone—multiple sclerosis	0.000171	0.000364	CcSEcCtD
Topiramate—Shock—Dexamethasone—multiple sclerosis	0.00017	0.000363	CcSEcCtD
Topiramate—Shock—Betamethasone—multiple sclerosis	0.00017	0.000363	CcSEcCtD
Topiramate—Dyspnoea—Triamcinolone—multiple sclerosis	0.00017	0.000362	CcSEcCtD
Topiramate—Nervous system disorder—Betamethasone—multiple sclerosis	0.00017	0.000362	CcSEcCtD
Topiramate—Nervous system disorder—Dexamethasone—multiple sclerosis	0.00017	0.000362	CcSEcCtD
Topiramate—Agitation—Prednisone—multiple sclerosis	0.00017	0.000362	CcSEcCtD
Topiramate—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000169	0.000361	CcSEcCtD
Topiramate—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000169	0.000361	CcSEcCtD
Topiramate—Tachycardia—Dexamethasone—multiple sclerosis	0.000169	0.00036	CcSEcCtD
Topiramate—Tachycardia—Betamethasone—multiple sclerosis	0.000169	0.00036	CcSEcCtD
Topiramate—GABRG2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000168	0.0018	CbGpPWpGaD
Topiramate—Dyspepsia—Triamcinolone—multiple sclerosis	0.000168	0.000358	CcSEcCtD
Topiramate—GRIA3—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.000168	0.00179	CbGpPWpGaD
Topiramate—Erythema multiforme—Methotrexate—multiple sclerosis	0.000168	0.000357	CcSEcCtD
Topiramate—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000168	0.000357	CcSEcCtD
Topiramate—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000167	0.000356	CcSEcCtD
Topiramate—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000167	0.000356	CcSEcCtD
Topiramate—CA9—Metabolism—SRM—multiple sclerosis	0.000167	0.00178	CbGpPWpGaD
Topiramate—CA12—Metabolism—GPC5—multiple sclerosis	0.000167	0.00178	CbGpPWpGaD
Topiramate—Malaise—Prednisone—multiple sclerosis	0.000167	0.000355	CcSEcCtD
Topiramate—Vertigo—Prednisone—multiple sclerosis	0.000166	0.000353	CcSEcCtD
Topiramate—Eye disorder—Methotrexate—multiple sclerosis	0.000166	0.000353	CcSEcCtD
Topiramate—Syncope—Prednisone—multiple sclerosis	0.000166	0.000353	CcSEcCtD
Topiramate—Tinnitus—Methotrexate—multiple sclerosis	0.000165	0.000352	CcSEcCtD
Topiramate—GABRG2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000165	0.00177	CbGpPWpGaD
Topiramate—Anorexia—Betamethasone—multiple sclerosis	0.000165	0.000351	CcSEcCtD
Topiramate—Anorexia—Dexamethasone—multiple sclerosis	0.000165	0.000351	CcSEcCtD
Topiramate—Urticaria—Prednisolone—multiple sclerosis	0.000165	0.000351	CcSEcCtD
Topiramate—Cardiac disorder—Methotrexate—multiple sclerosis	0.000165	0.000351	CcSEcCtD
Topiramate—Fatigue—Triamcinolone—multiple sclerosis	0.000164	0.00035	CcSEcCtD
Topiramate—Fatigue—Methylprednisolone—multiple sclerosis	0.000164	0.00035	CcSEcCtD
Topiramate—SCN1A—L1CAM interactions—MAPK1—multiple sclerosis	0.000164	0.00175	CbGpPWpGaD
Topiramate—Pain—Triamcinolone—multiple sclerosis	0.000163	0.000348	CcSEcCtD
Topiramate—Loss of consciousness—Prednisone—multiple sclerosis	0.000162	0.000346	CcSEcCtD
Topiramate—Hypotension—Betamethasone—multiple sclerosis	0.000162	0.000345	CcSEcCtD
Topiramate—Hypotension—Dexamethasone—multiple sclerosis	0.000162	0.000345	CcSEcCtD
Topiramate—Angiopathy—Methotrexate—multiple sclerosis	0.000161	0.000343	CcSEcCtD
Topiramate—Vomiting—Mitoxantrone—multiple sclerosis	0.000161	0.000342	CcSEcCtD
Topiramate—Immune system disorder—Methotrexate—multiple sclerosis	0.00016	0.000341	CcSEcCtD
Topiramate—Convulsion—Prednisone—multiple sclerosis	0.00016	0.000341	CcSEcCtD
Topiramate—Mediastinal disorder—Methotrexate—multiple sclerosis	0.00016	0.00034	CcSEcCtD
Topiramate—CA6—Metabolism—RRM1—multiple sclerosis	0.00016	0.00171	CbGpPWpGaD
Topiramate—CA5A—Metabolism—RRM1—multiple sclerosis	0.00016	0.00171	CbGpPWpGaD
Topiramate—Hypertension—Prednisone—multiple sclerosis	0.000159	0.00034	CcSEcCtD
Topiramate—Rash—Mitoxantrone—multiple sclerosis	0.000159	0.00034	CcSEcCtD
Topiramate—Dermatitis—Mitoxantrone—multiple sclerosis	0.000159	0.000339	CcSEcCtD
Topiramate—Chills—Methotrexate—multiple sclerosis	0.000159	0.000339	CcSEcCtD
Topiramate—Headache—Mitoxantrone—multiple sclerosis	0.000158	0.000337	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000158	0.000336	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000158	0.000336	CcSEcCtD
Topiramate—Myalgia—Prednisone—multiple sclerosis	0.000157	0.000335	CcSEcCtD
Topiramate—Arthralgia—Prednisone—multiple sclerosis	0.000157	0.000335	CcSEcCtD
Topiramate—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000157	0.000335	CcSEcCtD
Topiramate—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000157	0.000334	CcSEcCtD
Topiramate—Anxiety—Prednisone—multiple sclerosis	0.000157	0.000334	CcSEcCtD
Topiramate—Alopecia—Methotrexate—multiple sclerosis	0.000157	0.000334	CcSEcCtD
Topiramate—Insomnia—Betamethasone—multiple sclerosis	0.000157	0.000333	CcSEcCtD
Topiramate—Insomnia—Dexamethasone—multiple sclerosis	0.000157	0.000333	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000156	0.000333	CcSEcCtD
Topiramate—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000156	0.000332	CcSEcCtD
Topiramate—Paraesthesia—Dexamethasone—multiple sclerosis	0.000155	0.000331	CcSEcCtD
Topiramate—Paraesthesia—Betamethasone—multiple sclerosis	0.000155	0.000331	CcSEcCtD
Topiramate—Discomfort—Prednisone—multiple sclerosis	0.000155	0.000331	CcSEcCtD
Topiramate—Mental disorder—Methotrexate—multiple sclerosis	0.000155	0.000331	CcSEcCtD
Topiramate—SCN1A—Developmental Biology—PTPRC—multiple sclerosis	0.000155	0.00166	CbGpPWpGaD
Topiramate—Erythema—Methotrexate—multiple sclerosis	0.000154	0.000329	CcSEcCtD
Topiramate—Malnutrition—Methotrexate—multiple sclerosis	0.000154	0.000329	CcSEcCtD
Topiramate—SCN5A—Axon guidance—PTPRC—multiple sclerosis	0.000153	0.00163	CbGpPWpGaD
Topiramate—Hypersensitivity—Prednisolone—multiple sclerosis	0.000153	0.000326	CcSEcCtD
Topiramate—Dyspepsia—Dexamethasone—multiple sclerosis	0.000152	0.000325	CcSEcCtD
Topiramate—Dyspepsia—Betamethasone—multiple sclerosis	0.000152	0.000325	CcSEcCtD
Topiramate—Urticaria—Triamcinolone—multiple sclerosis	0.000152	0.000323	CcSEcCtD
Topiramate—Urticaria—Methylprednisolone—multiple sclerosis	0.000151	0.000322	CcSEcCtD
Topiramate—Dysgeusia—Methotrexate—multiple sclerosis	0.000151	0.000322	CcSEcCtD
Topiramate—Body temperature increased—Triamcinolone—multiple sclerosis	0.000151	0.000321	CcSEcCtD
Topiramate—Oedema—Prednisone—multiple sclerosis	0.000151	0.000321	CcSEcCtD
Topiramate—Abdominal pain—Methylprednisolone—multiple sclerosis	0.00015	0.000321	CcSEcCtD
Topiramate—Decreased appetite—Betamethasone—multiple sclerosis	0.00015	0.000321	CcSEcCtD
Topiramate—Decreased appetite—Dexamethasone—multiple sclerosis	0.00015	0.000321	CcSEcCtD
Topiramate—Nausea—Mitoxantrone—multiple sclerosis	0.00015	0.00032	CcSEcCtD
Topiramate—Infection—Prednisone—multiple sclerosis	0.00015	0.000319	CcSEcCtD
Topiramate—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000149	0.000318	CcSEcCtD
Topiramate—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000149	0.000318	CcSEcCtD
Topiramate—Back pain—Methotrexate—multiple sclerosis	0.000149	0.000318	CcSEcCtD
Topiramate—Fatigue—Betamethasone—multiple sclerosis	0.000149	0.000318	CcSEcCtD
Topiramate—Fatigue—Dexamethasone—multiple sclerosis	0.000149	0.000318	CcSEcCtD
Topiramate—CA5B—Metabolism—RRM1—multiple sclerosis	0.000149	0.00159	CbGpPWpGaD
Topiramate—CA7—Metabolism—RRM1—multiple sclerosis	0.000149	0.00159	CbGpPWpGaD
Topiramate—Shock—Prednisone—multiple sclerosis	0.000148	0.000316	CcSEcCtD
Topiramate—Pain—Dexamethasone—multiple sclerosis	0.000148	0.000315	CcSEcCtD
Topiramate—Pain—Betamethasone—multiple sclerosis	0.000148	0.000315	CcSEcCtD
Topiramate—Nervous system disorder—Prednisone—multiple sclerosis	0.000148	0.000315	CcSEcCtD
Topiramate—Tachycardia—Prednisone—multiple sclerosis	0.000147	0.000313	CcSEcCtD
Topiramate—GABRA1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000147	0.00157	CbGpPWpGaD
Topiramate—Skin disorder—Prednisone—multiple sclerosis	0.000146	0.000312	CcSEcCtD
Topiramate—Hyperhidrosis—Prednisone—multiple sclerosis	0.000146	0.00031	CcSEcCtD
Topiramate—Vision blurred—Methotrexate—multiple sclerosis	0.000145	0.00031	CcSEcCtD
Topiramate—CA4—Metabolism—CYP27B1—multiple sclerosis	0.000145	0.00155	CbGpPWpGaD
Topiramate—CA4—Metabolism—CYP24A1—multiple sclerosis	0.000145	0.00155	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000144	0.00154	CbGpPWpGaD
Topiramate—GRIA1—BDNF signaling pathway—STAT3—multiple sclerosis	0.000144	0.00154	CbGpPWpGaD
Topiramate—Anorexia—Prednisone—multiple sclerosis	0.000144	0.000306	CcSEcCtD
Topiramate—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000143	0.000305	CcSEcCtD
Topiramate—Anaemia—Methotrexate—multiple sclerosis	0.000143	0.000304	CcSEcCtD
Topiramate—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000143	0.000304	CcSEcCtD
Topiramate—Feeling abnormal—Betamethasone—multiple sclerosis	0.000143	0.000304	CcSEcCtD
Topiramate—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000142	0.000302	CcSEcCtD
Topiramate—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000142	0.000302	CcSEcCtD
Topiramate—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000141	0.000299	CcSEcCtD
Topiramate—SCN5A—Developmental Biology—PRNP—multiple sclerosis	0.00014	0.0015	CbGpPWpGaD
Topiramate—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.00014	0.000299	CcSEcCtD
Topiramate—CA2—Metabolism—CYP24A1—multiple sclerosis	0.000139	0.00149	CbGpPWpGaD
Topiramate—CA2—Metabolism—CYP27B1—multiple sclerosis	0.000139	0.00149	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000139	0.00149	CbGpPWpGaD
Topiramate—Malaise—Methotrexate—multiple sclerosis	0.000139	0.000297	CcSEcCtD
Topiramate—Vertigo—Methotrexate—multiple sclerosis	0.000139	0.000295	CcSEcCtD
Topiramate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000138	0.00148	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—BCHE—multiple sclerosis	0.000138	0.00148	CbGpPWpGaD
Topiramate—Leukopenia—Methotrexate—multiple sclerosis	0.000138	0.000294	CcSEcCtD
Topiramate—CA12—Metabolism—RRM1—multiple sclerosis	0.000138	0.00148	CbGpPWpGaD
Topiramate—Urticaria—Dexamethasone—multiple sclerosis	0.000138	0.000293	CcSEcCtD
Topiramate—Urticaria—Betamethasone—multiple sclerosis	0.000138	0.000293	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000137	0.000293	CcSEcCtD
Topiramate—Dizziness—Prednisolone—multiple sclerosis	0.000137	0.000292	CcSEcCtD
Topiramate—Asthenia—Triamcinolone—multiple sclerosis	0.000137	0.000292	CcSEcCtD
Topiramate—Abdominal pain—Betamethasone—multiple sclerosis	0.000137	0.000291	CcSEcCtD
Topiramate—Body temperature increased—Dexamethasone—multiple sclerosis	0.000137	0.000291	CcSEcCtD
Topiramate—Abdominal pain—Dexamethasone—multiple sclerosis	0.000137	0.000291	CcSEcCtD
Topiramate—Body temperature increased—Betamethasone—multiple sclerosis	0.000137	0.000291	CcSEcCtD
Topiramate—Asthenia—Methylprednisolone—multiple sclerosis	0.000137	0.000291	CcSEcCtD
Topiramate—Insomnia—Prednisone—multiple sclerosis	0.000136	0.00029	CcSEcCtD
Topiramate—Paraesthesia—Prednisone—multiple sclerosis	0.000135	0.000288	CcSEcCtD
Topiramate—Pruritus—Triamcinolone—multiple sclerosis	0.000135	0.000288	CcSEcCtD
Topiramate—GABRA1—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.000135	0.00144	CbGpPWpGaD
Topiramate—Cough—Methotrexate—multiple sclerosis	0.000135	0.000287	CcSEcCtD
Topiramate—Pruritus—Methylprednisolone—multiple sclerosis	0.000135	0.000287	CcSEcCtD
Topiramate—Convulsion—Methotrexate—multiple sclerosis	0.000134	0.000285	CcSEcCtD
Topiramate—GRIA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	0.000134	0.00143	CbGpPWpGaD
Topiramate—CA1—Metabolism—CYP27B1—multiple sclerosis	0.000134	0.00143	CbGpPWpGaD
Topiramate—CA1—Metabolism—CYP24A1—multiple sclerosis	0.000134	0.00143	CbGpPWpGaD
Topiramate—CA4—Metabolism—GPC5—multiple sclerosis	0.000133	0.00142	CbGpPWpGaD
Topiramate—Dyspepsia—Prednisone—multiple sclerosis	0.000133	0.000283	CcSEcCtD
Topiramate—Arthralgia—Methotrexate—multiple sclerosis	0.000131	0.00028	CcSEcCtD
Topiramate—Myalgia—Methotrexate—multiple sclerosis	0.000131	0.00028	CcSEcCtD
Topiramate—Chest pain—Methotrexate—multiple sclerosis	0.000131	0.00028	CcSEcCtD
Topiramate—Decreased appetite—Prednisone—multiple sclerosis	0.000131	0.000279	CcSEcCtD
Topiramate—Rash—Prednisolone—multiple sclerosis	0.000131	0.000279	CcSEcCtD
Topiramate—GRIA1—BDNF signaling pathway—MAPK1—multiple sclerosis	0.000131	0.0014	CbGpPWpGaD
Topiramate—Dermatitis—Prednisolone—multiple sclerosis	0.000131	0.000278	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000131	0.000278	CcSEcCtD
Topiramate—Diarrhoea—Methylprednisolone—multiple sclerosis	0.00013	0.000277	CcSEcCtD
Topiramate—Fatigue—Prednisone—multiple sclerosis	0.00013	0.000277	CcSEcCtD
Topiramate—Headache—Prednisolone—multiple sclerosis	0.00013	0.000277	CcSEcCtD
Topiramate—Discomfort—Methotrexate—multiple sclerosis	0.00013	0.000277	CcSEcCtD
Topiramate—Constipation—Prednisone—multiple sclerosis	0.000129	0.000275	CcSEcCtD
Topiramate—GABRA1—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.000129	0.00138	CbGpPWpGaD
Topiramate—GRIA3—Neuronal System—MAPK1—multiple sclerosis	0.000129	0.00137	CbGpPWpGaD
Topiramate—CA2—Metabolism—GPC5—multiple sclerosis	0.000127	0.00136	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000127	0.00136	CbGpPWpGaD
Topiramate—Confusional state—Methotrexate—multiple sclerosis	0.000127	0.000271	CcSEcCtD
Topiramate—GABRG2—Neuronal System—BCHE—multiple sclerosis	0.000127	0.00135	CbGpPWpGaD
Topiramate—Dizziness—Triamcinolone—multiple sclerosis	0.000126	0.000269	CcSEcCtD
Topiramate—Dizziness—Methylprednisolone—multiple sclerosis	0.000126	0.000268	CcSEcCtD
Topiramate—Infection—Methotrexate—multiple sclerosis	0.000125	0.000267	CcSEcCtD
Topiramate—Feeling abnormal—Prednisone—multiple sclerosis	0.000124	0.000265	CcSEcCtD
Topiramate—Asthenia—Dexamethasone—multiple sclerosis	0.000124	0.000265	CcSEcCtD
Topiramate—Asthenia—Betamethasone—multiple sclerosis	0.000124	0.000265	CcSEcCtD
Topiramate—Nervous system disorder—Methotrexate—multiple sclerosis	0.000124	0.000263	CcSEcCtD
Topiramate—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000123	0.000263	CcSEcCtD
Topiramate—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000123	0.000263	CcSEcCtD
Topiramate—Nausea—Prednisolone—multiple sclerosis	0.000123	0.000262	CcSEcCtD
Topiramate—Pruritus—Dexamethasone—multiple sclerosis	0.000122	0.000261	CcSEcCtD
Topiramate—Pruritus—Betamethasone—multiple sclerosis	0.000122	0.000261	CcSEcCtD
Topiramate—Skin disorder—Methotrexate—multiple sclerosis	0.000122	0.000261	CcSEcCtD
Topiramate—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	0.000122	0.00131	CbGpPWpGaD
Topiramate—CA1—Metabolism—GPC5—multiple sclerosis	0.000122	0.00131	CbGpPWpGaD
Topiramate—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000122	0.000259	CcSEcCtD
Topiramate—Vomiting—Triamcinolone—multiple sclerosis	0.000121	0.000258	CcSEcCtD
Topiramate—Vomiting—Methylprednisolone—multiple sclerosis	0.000121	0.000258	CcSEcCtD
Topiramate—Rash—Triamcinolone—multiple sclerosis	0.00012	0.000256	CcSEcCtD
Topiramate—Dermatitis—Triamcinolone—multiple sclerosis	0.00012	0.000256	CcSEcCtD
Topiramate—Anorexia—Methotrexate—multiple sclerosis	0.00012	0.000256	CcSEcCtD
Topiramate—Rash—Methylprednisolone—multiple sclerosis	0.00012	0.000256	CcSEcCtD
Topiramate—Dermatitis—Methylprednisolone—multiple sclerosis	0.00012	0.000255	CcSEcCtD
Topiramate—Urticaria—Prednisone—multiple sclerosis	0.00012	0.000255	CcSEcCtD
Topiramate—Headache—Triamcinolone—multiple sclerosis	0.00012	0.000255	CcSEcCtD
Topiramate—Headache—Methylprednisolone—multiple sclerosis	0.000119	0.000254	CcSEcCtD
Topiramate—Abdominal pain—Prednisone—multiple sclerosis	0.000119	0.000254	CcSEcCtD
Topiramate—Body temperature increased—Prednisone—multiple sclerosis	0.000119	0.000254	CcSEcCtD
Topiramate—Diarrhoea—Dexamethasone—multiple sclerosis	0.000118	0.000252	CcSEcCtD
Topiramate—Diarrhoea—Betamethasone—multiple sclerosis	0.000118	0.000252	CcSEcCtD
Topiramate—Hypotension—Methotrexate—multiple sclerosis	0.000118	0.000251	CcSEcCtD
Topiramate—CA9—Metabolism—CYP24A1—multiple sclerosis	0.000117	0.00126	CbGpPWpGaD
Topiramate—CA9—Metabolism—CYP27B1—multiple sclerosis	0.000117	0.00126	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000116	0.00124	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000116	0.00124	CbGpPWpGaD
Topiramate—SCN5A—L1CAM interactions—MAPK1—multiple sclerosis	0.000115	0.00123	CbGpPWpGaD
Topiramate—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000115	0.000244	CcSEcCtD
Topiramate—Dizziness—Betamethasone—multiple sclerosis	0.000114	0.000244	CcSEcCtD
Topiramate—Dizziness—Dexamethasone—multiple sclerosis	0.000114	0.000244	CcSEcCtD
Topiramate—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000114	0.00122	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000114	0.00122	CbGpPWpGaD
Topiramate—Insomnia—Methotrexate—multiple sclerosis	0.000114	0.000243	CcSEcCtD
Topiramate—Nausea—Triamcinolone—multiple sclerosis	0.000113	0.000241	CcSEcCtD
Topiramate—Paraesthesia—Methotrexate—multiple sclerosis	0.000113	0.000241	CcSEcCtD
Topiramate—Nausea—Methylprednisolone—multiple sclerosis	0.000113	0.000241	CcSEcCtD
Topiramate—Dyspnoea—Methotrexate—multiple sclerosis	0.000112	0.000239	CcSEcCtD
Topiramate—Somnolence—Methotrexate—multiple sclerosis	0.000112	0.000239	CcSEcCtD
Topiramate—GABRA1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000111	0.00119	CbGpPWpGaD
Topiramate—Hypersensitivity—Prednisone—multiple sclerosis	0.000111	0.000237	CcSEcCtD
Topiramate—Dyspepsia—Methotrexate—multiple sclerosis	0.000111	0.000236	CcSEcCtD
Topiramate—GABRA1—Neuronal System—BCHE—multiple sclerosis	0.000111	0.00118	CbGpPWpGaD
Topiramate—CA4—Metabolism—RRM1—multiple sclerosis	0.00011	0.00118	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.00011	0.00118	CbGpPWpGaD
Topiramate—Vomiting—Betamethasone—multiple sclerosis	0.00011	0.000234	CcSEcCtD
Topiramate—Vomiting—Dexamethasone—multiple sclerosis	0.00011	0.000234	CcSEcCtD
Topiramate—Decreased appetite—Methotrexate—multiple sclerosis	0.00011	0.000233	CcSEcCtD
Topiramate—Rash—Betamethasone—multiple sclerosis	0.000109	0.000232	CcSEcCtD
Topiramate—Rash—Dexamethasone—multiple sclerosis	0.000109	0.000232	CcSEcCtD
Topiramate—SCN5A—Developmental Biology—PTPRC—multiple sclerosis	0.000109	0.00117	CbGpPWpGaD
Topiramate—Dermatitis—Betamethasone—multiple sclerosis	0.000109	0.000232	CcSEcCtD
Topiramate—Dermatitis—Dexamethasone—multiple sclerosis	0.000109	0.000232	CcSEcCtD
Topiramate—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000109	0.000232	CcSEcCtD
Topiramate—Fatigue—Methotrexate—multiple sclerosis	0.000109	0.000231	CcSEcCtD
Topiramate—Headache—Dexamethasone—multiple sclerosis	0.000108	0.000231	CcSEcCtD
Topiramate—Headache—Betamethasone—multiple sclerosis	0.000108	0.000231	CcSEcCtD
Topiramate—Asthenia—Prednisone—multiple sclerosis	0.000108	0.00023	CcSEcCtD
Topiramate—Pain—Methotrexate—multiple sclerosis	0.000108	0.000229	CcSEcCtD
Topiramate—CA9—Metabolism—GPC5—multiple sclerosis	0.000107	0.00115	CbGpPWpGaD
Topiramate—Pruritus—Prednisone—multiple sclerosis	0.000107	0.000227	CcSEcCtD
Topiramate—CA2—Metabolism—RRM1—multiple sclerosis	0.000106	0.00113	CbGpPWpGaD
Topiramate—Feeling abnormal—Methotrexate—multiple sclerosis	0.000104	0.000221	CcSEcCtD
Topiramate—Diarrhoea—Prednisone—multiple sclerosis	0.000103	0.00022	CcSEcCtD
Topiramate—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000103	0.000219	CcSEcCtD
Topiramate—Nausea—Betamethasone—multiple sclerosis	0.000103	0.000219	CcSEcCtD
Topiramate—Nausea—Dexamethasone—multiple sclerosis	0.000103	0.000219	CcSEcCtD
Topiramate—SCN5A—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	0.000103	0.0011	CbGpPWpGaD
Topiramate—CA1—Metabolism—RRM1—multiple sclerosis	0.000101	0.00108	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000101	0.00108	CbGpPWpGaD
Topiramate—GRIA2—BDNF signaling pathway—STAT3—multiple sclerosis	0.000101	0.00107	CbGpPWpGaD
Topiramate—GRIA1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.0001	0.00107	CbGpPWpGaD
Topiramate—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.0001	0.00107	CbGpPWpGaD
Topiramate—Urticaria—Methotrexate—multiple sclerosis	0.0001	0.000213	CcSEcCtD
Topiramate—Dizziness—Prednisone—multiple sclerosis	9.97e-05	0.000212	CcSEcCtD
Topiramate—Abdominal pain—Methotrexate—multiple sclerosis	9.96e-05	0.000212	CcSEcCtD
Topiramate—Body temperature increased—Methotrexate—multiple sclerosis	9.96e-05	0.000212	CcSEcCtD
Topiramate—GABRB2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	9.74e-05	0.00104	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—TYK2—multiple sclerosis	9.73e-05	0.00104	CbGpPWpGaD
Topiramate—Vomiting—Prednisone—multiple sclerosis	9.59e-05	0.000204	CcSEcCtD
Topiramate—Rash—Prednisone—multiple sclerosis	9.51e-05	0.000202	CcSEcCtD
Topiramate—Dermatitis—Prednisone—multiple sclerosis	9.5e-05	0.000202	CcSEcCtD
Topiramate—Headache—Prednisone—multiple sclerosis	9.44e-05	0.000201	CcSEcCtD
Topiramate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	9.35e-05	0.000999	CbGpPWpGaD
Topiramate—Hypersensitivity—Methotrexate—multiple sclerosis	9.28e-05	0.000198	CcSEcCtD
Topiramate—GRIK2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	9.19e-05	0.000982	CbGpPWpGaD
Topiramate—CA5A—Metabolism—BCHE—multiple sclerosis	9.18e-05	0.00098	CbGpPWpGaD
Topiramate—CA6—Metabolism—BCHE—multiple sclerosis	9.18e-05	0.00098	CbGpPWpGaD
Topiramate—GRIA2—BDNF signaling pathway—MAPK1—multiple sclerosis	9.14e-05	0.000977	CbGpPWpGaD
Topiramate—Asthenia—Methotrexate—multiple sclerosis	9.04e-05	0.000193	CcSEcCtD
Topiramate—Nausea—Prednisone—multiple sclerosis	8.95e-05	0.000191	CcSEcCtD
Topiramate—Pruritus—Methotrexate—multiple sclerosis	8.91e-05	0.00019	CcSEcCtD
Topiramate—GABRG2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	8.91e-05	0.000952	CbGpPWpGaD
Topiramate—CA9—Metabolism—RRM1—multiple sclerosis	8.9e-05	0.000951	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	8.81e-05	0.000941	CbGpPWpGaD
Topiramate—Diarrhoea—Methotrexate—multiple sclerosis	8.62e-05	0.000184	CcSEcCtD
Topiramate—CA5B—Metabolism—BCHE—multiple sclerosis	8.57e-05	0.000915	CbGpPWpGaD
Topiramate—CA7—Metabolism—BCHE—multiple sclerosis	8.57e-05	0.000915	CbGpPWpGaD
Topiramate—Dizziness—Methotrexate—multiple sclerosis	8.33e-05	0.000177	CcSEcCtD
Topiramate—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.14e-05	0.00087	CbGpPWpGaD
Topiramate—Vomiting—Methotrexate—multiple sclerosis	8.01e-05	0.000171	CcSEcCtD
Topiramate—Rash—Methotrexate—multiple sclerosis	7.94e-05	0.000169	CcSEcCtD
Topiramate—Dermatitis—Methotrexate—multiple sclerosis	7.94e-05	0.000169	CcSEcCtD
Topiramate—CA12—Metabolism—BCHE—multiple sclerosis	7.94e-05	0.000848	CbGpPWpGaD
Topiramate—Headache—Methotrexate—multiple sclerosis	7.89e-05	0.000168	CcSEcCtD
Topiramate—GABRA1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	7.78e-05	0.000832	CbGpPWpGaD
Topiramate—GRIA1—Neuronal System—MAPK1—multiple sclerosis	7.7e-05	0.000823	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—MMP9—multiple sclerosis	7.66e-05	0.000819	CbGpPWpGaD
Topiramate—Nausea—Methotrexate—multiple sclerosis	7.48e-05	0.000159	CcSEcCtD
Topiramate—SCN5A—SIDS Susceptibility Pathways—TNF—multiple sclerosis	7.44e-05	0.000795	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	7.39e-05	0.000789	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	7.39e-05	0.000789	CbGpPWpGaD
Topiramate—GRIK2—Neuronal System—MAPK1—multiple sclerosis	7.04e-05	0.000752	CbGpPWpGaD
Topiramate—GRIA2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	7.03e-05	0.000751	CbGpPWpGaD
Topiramate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	7.02e-05	0.00075	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—TYK2—multiple sclerosis	6.94e-05	0.000742	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—TYK2—multiple sclerosis	6.84e-05	0.000731	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—STAT3—multiple sclerosis	6.82e-05	0.000729	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	6.76e-05	0.000722	CbGpPWpGaD
Topiramate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	6.42e-05	0.000686	CbGpPWpGaD
Topiramate—CA4—Metabolism—BCHE—multiple sclerosis	6.33e-05	0.000676	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—MAPK1—multiple sclerosis	6.2e-05	0.000663	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—MAPK1—multiple sclerosis	6.19e-05	0.000662	CbGpPWpGaD
Topiramate—CA2—Metabolism—BCHE—multiple sclerosis	6.07e-05	0.000648	CbGpPWpGaD
Topiramate—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.04e-05	0.000646	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—IL6—multiple sclerosis	6e-05	0.000641	CbGpPWpGaD
Topiramate—CA1—Metabolism—BCHE—multiple sclerosis	5.82e-05	0.000622	CbGpPWpGaD
Topiramate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	5.61e-05	0.0006	CbGpPWpGaD
Topiramate—CA5A—Metabolism—APOE—multiple sclerosis	5.52e-05	0.00059	CbGpPWpGaD
Topiramate—CA6—Metabolism—APOE—multiple sclerosis	5.52e-05	0.00059	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—MMP9—multiple sclerosis	5.47e-05	0.000584	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—MMP9—multiple sclerosis	5.39e-05	0.000576	CbGpPWpGaD
Topiramate—GRIA2—Neuronal System—MAPK1—multiple sclerosis	5.39e-05	0.000575	CbGpPWpGaD
Topiramate—GABRB2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	5.28e-05	0.000564	CbGpPWpGaD
Topiramate—CA5B—Metabolism—APOE—multiple sclerosis	5.15e-05	0.000551	CbGpPWpGaD
Topiramate—CA7—Metabolism—APOE—multiple sclerosis	5.15e-05	0.000551	CbGpPWpGaD
Topiramate—CA9—Metabolism—BCHE—multiple sclerosis	5.11e-05	0.000546	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—TNF—multiple sclerosis	4.9e-05	0.000524	CbGpPWpGaD
Topiramate—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.9e-05	0.000523	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—TYK2—multiple sclerosis	4.88e-05	0.000522	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—STAT3—multiple sclerosis	4.86e-05	0.000519	CbGpPWpGaD
Topiramate—GABRG2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	4.83e-05	0.000516	CbGpPWpGaD
Topiramate—CA12—Metabolism—APOE—multiple sclerosis	4.77e-05	0.00051	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—IL6—multiple sclerosis	4.77e-05	0.000509	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—IL6—multiple sclerosis	4.76e-05	0.000508	CbGpPWpGaD
Topiramate—CA6—Metabolism—POMC—multiple sclerosis	4.74e-05	0.000507	CbGpPWpGaD
Topiramate—CA5A—Metabolism—POMC—multiple sclerosis	4.74e-05	0.000507	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SRM—multiple sclerosis	4.67e-05	0.000499	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—TGFB1—multiple sclerosis	4.51e-05	0.000482	CbGpPWpGaD
Topiramate—CA7—Metabolism—POMC—multiple sclerosis	4.43e-05	0.000473	CbGpPWpGaD
Topiramate—CA5B—Metabolism—POMC—multiple sclerosis	4.43e-05	0.000473	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—MAPK1—multiple sclerosis	4.42e-05	0.000472	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—MAPK1—multiple sclerosis	4.35e-05	0.000465	CbGpPWpGaD
Topiramate—CYP2C19—Biological oxidations—POMC—multiple sclerosis	4.33e-05	0.000462	CbGpPWpGaD
Topiramate—CA6—Metabolism—ALB—multiple sclerosis	4.32e-05	0.000462	CbGpPWpGaD
Topiramate—CA5A—Metabolism—ALB—multiple sclerosis	4.32e-05	0.000462	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	4.22e-05	0.000451	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—TNF—multiple sclerosis	4.21e-05	0.00045	CbGpPWpGaD
Topiramate—CA12—Metabolism—POMC—multiple sclerosis	4.1e-05	0.000438	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—MAPK1—multiple sclerosis	4.04e-05	0.000432	CbGpPWpGaD
Topiramate—CA7—Metabolism—ALB—multiple sclerosis	4.04e-05	0.000431	CbGpPWpGaD
Topiramate—CA5B—Metabolism—ALB—multiple sclerosis	4.04e-05	0.000431	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—IL6—multiple sclerosis	3.96e-05	0.000423	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—MMP9—multiple sclerosis	3.84e-05	0.000411	CbGpPWpGaD
Topiramate—CA4—Metabolism—APOE—multiple sclerosis	3.81e-05	0.000407	CbGpPWpGaD
Topiramate—CA12—Metabolism—ALB—multiple sclerosis	3.74e-05	0.0004	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—MAPK1—multiple sclerosis	3.7e-05	0.000395	CbGpPWpGaD
Topiramate—CA2—Metabolism—APOE—multiple sclerosis	3.65e-05	0.00039	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.51e-05	0.000375	CbGpPWpGaD
Topiramate—CA1—Metabolism—APOE—multiple sclerosis	3.5e-05	0.000374	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—STAT3—multiple sclerosis	3.42e-05	0.000365	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—IL6—multiple sclerosis	3.4e-05	0.000363	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—IL6—multiple sclerosis	3.35e-05	0.000357	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	3.29e-05	0.000351	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	3.29e-05	0.000351	CbGpPWpGaD
Topiramate—CA4—Metabolism—POMC—multiple sclerosis	3.27e-05	0.000349	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—MAPK1—multiple sclerosis	3.23e-05	0.000345	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.21e-05	0.000343	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.21e-05	0.000343	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—TGFB1—multiple sclerosis	3.17e-05	0.000339	CbGpPWpGaD
Topiramate—CA2—Metabolism—POMC—multiple sclerosis	3.14e-05	0.000335	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—MAPK1—multiple sclerosis	3.11e-05	0.000332	CbGpPWpGaD
Topiramate—CA9—Metabolism—APOE—multiple sclerosis	3.08e-05	0.000329	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GPC5—multiple sclerosis	3.01e-05	0.000321	CbGpPWpGaD
Topiramate—CA1—Metabolism—POMC—multiple sclerosis	3.01e-05	0.000321	CbGpPWpGaD
Topiramate—CA4—Metabolism—ALB—multiple sclerosis	2.98e-05	0.000319	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—TNF—multiple sclerosis	2.96e-05	0.000316	CbGpPWpGaD
Topiramate—CA2—Metabolism—ALB—multiple sclerosis	2.86e-05	0.000305	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SRM—multiple sclerosis	2.81e-05	0.0003	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.8e-05	0.000299	CbGpPWpGaD
Topiramate—CA1—Metabolism—ALB—multiple sclerosis	2.74e-05	0.000293	CbGpPWpGaD
Topiramate—CA9—Metabolism—POMC—multiple sclerosis	2.64e-05	0.000282	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.6e-05	0.000278	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—RRM1—multiple sclerosis	2.49e-05	0.000266	CbGpPWpGaD
Topiramate—CA9—Metabolism—ALB—multiple sclerosis	2.41e-05	0.000257	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—IL6—multiple sclerosis	2.39e-05	0.000255	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.98e-05	0.000211	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.98e-05	0.000211	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.93e-05	0.000207	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.81e-05	0.000193	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.66e-05	0.000178	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.51e-05	0.000162	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.5e-05	0.00016	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.43e-05	0.000153	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—APOE—multiple sclerosis	8.61e-06	9.2e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—BCHE—multiple sclerosis	8.61e-06	9.2e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—POMC—multiple sclerosis	7.4e-06	7.91e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ALB—multiple sclerosis	6.75e-06	7.21e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—APOE—multiple sclerosis	5.18e-06	5.53e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—POMC—multiple sclerosis	4.45e-06	4.75e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ALB—multiple sclerosis	4.06e-06	4.33e-05	CbGpPWpGaD
